CRISPR Archives - Page 11 of 12

Stanford Human Germline Modification Meeting: Medicine, Science, Ethics, & Law

May 18, 2015 / Professor Paul Knoepfler, Ph.D.

Last Thursday I participated in a meeting at Stanford Law School on human germline genetic modification hosted by Hank Greely (pictured at left), Professor of Law and Genetics at Stanford. The meeting was entitled, “Human Germline Modification: Medicine, Science, Ethics, and Law”. The panel included in addition to Hank and me, the following speakers: Marcy Darnovsky, Executive Director of […]

Stanford Human Germline Modification Meeting: Medicine, Science, Ethics, & Law Read More »

Doudna most deserving of CRISPR Cas9 patent, says poll

May 3, 2015 / Professor Paul Knoepfler, Ph.D. / 4 Comments

With more than 250 votes cast, Jennifer Doudna is leading by a decisive margin in a poll asking who deserves the patent for use of CRISPR-Cas9 as a tool. Feng Zhang got only just over half the votes of Doudna. Another take home message from this poll is that a sizable minority–almost one in five– said

Doudna most deserving of CRISPR Cas9 patent, says poll Read More »

News bites & rumors on human embryo genetic modification

April 30, 2015 / Professor Paul Knoepfler, Ph.D. / 8 Comments

A lot has happened in the week since the first human embryo genetic modification paper was published by a team led by Junjiu Huang. There have been a number of new events just in the last few days. Jocelyn Kaiser over at SCIENCEINSIDER has a new piece reporting a couple important developments including that the journal

News bites & rumors on human embryo genetic modification Read More »

‘Roundup Ready’ Humans?

April 28, 2015 / Professor Paul Knoepfler, Ph.D. / 3 Comments

‘Roundup Ready’ Humans? What the heck does that mean? One of my favorite parts of doing a blog is getting reader comments. It definitely makes the blogging experience more fun and keeps me on my toes. I also learn a lot. The more discussion there is, the better. One of the most frequent commenters is

‘Roundup Ready’ Humans? Read More »

Who deserves patent for CRISPR-Cas9 in human cells? Take our poll

April 21, 2015 / Professor Paul Knoepfler, Ph.D. / 6 Comments

There is no hotter technology than CRISPR-Cas9 gene editing tools. Perhaps it is not surprising then that there is a patent dispute over it, which falls into two camps: (1) Jennifer Doudna & Emmanuelle Charpentier, and (2) Feng Zhang. Who deserves the intellectual property for use of CRISPR-Cas9 in human cells? Take our poll.

Who deserves patent for CRISPR-Cas9 in human cells? Take our poll Read More »

5 new cool papers on CRISPR Cas9 gene editing

April 8, 2015 / Professor Paul Knoepfler, Ph.D.

CRISPR Cas9 is a relatively new, powerful approach to gene editing and genetic modification more generally. In the relatively short window of time in which this technology has been widely available for gene editing applications it has already evolved rapidly to become more powerful. Here are some new papers of interest on this technology. With

5 new cool papers on CRISPR Cas9 gene editing Read More »

TGIF: Stem Cell Stream of Consciousness Including CRISPR

April 3, 2015 / Professor Paul Knoepfler, Ph.D.

It seems like Fridays are always a good time for reflection. It’s not like the scientist’s week ends on Friday sad to say, but still at least we can pause momentarily TGIF style and reflect on the maelstrom that is our lives, while cracking open another diet Coke or pouring another cup of coffee. This

TGIF: Stem Cell Stream of Consciousness Including CRISPR Read More »

Practical Plan for Managing Human Germline CRISPR

March 20, 2015 / Professor Paul Knoepfler, Ph.D. / 4 Comments

CRISPR Cas9 gene editing technology is a game changer on many levels both inside and soon outside the lab. There is a growing sense of urgency amongst biomedical scientists to take a proactive approach to current and future use of CRISPR gene editing technology in human germ cells and embryos. These concerns have been heightened

Practical Plan for Managing Human Germline CRISPR Read More »

ISSCR calls for moratorium on clinical application of human germline nuclear genome editing

March 19, 2015 / Professor Paul Knoepfler, Ph.D.

The International Society for Stem Cell Research (ISSCR) just now released a new policy statement on human germline gene editing. The statement calls for a ban on clinical application of human germline gene editing technology. Here is the brief summary statement at the beginning: The International Society for Stem Cell Research calls for a moratorium on

ISSCR calls for moratorium on clinical application of human germline nuclear genome editing Read More »

Intensifying dialogue on human germline gene editing

March 19, 2015 / Professor Paul Knoepfler, Ph.D. / 1 Comment

The field recently saw Lanphier, et al. in Nature calling for a moratorium on human germilne CRISPR genetic modification. A number of additional stakeholders are expected to be weighing in soon on the issue of human germline gene editing. For example, a Science paper from others in the gene editing community is anticipated soon and may well have somewhat different perspectives. I’ve been

Intensifying dialogue on human germline gene editing Read More »

CRISPR

Subscribe to Our Newsletter